Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Musikkintervensjon og transkraniell elektrisk stimulering for nevrologiske sykdommer

5. november 2026 oppdatert av: Istituti Clinici Scientifici Maugeri SpA

Musikkintervensjon og transkraniell elektrisk stimulering for behandling av nevrologiske sykdommer

The goal of this clinical trial is to evaluate the efficacy of a musical interventionand non-invasive brain stimulation in neurological patients. The main questions it aims to answer are:

  • to evaluate the residual neuroplastic processes in DOC state related to music exposure
  • to determine the putative modulation of the aforementioned processes and the clinical outcome of DOC patients by non-pharmacological strategies, i.e., electric (tDCS) and music stimulation
  • to evaluate the impact of this intervention on caregiver's burden and psychological distress.

Participants will be randomly assigned to one of three different music-listening intervention groups. Primary outcomes will be clinical, that is based on the neurologist's observations of clinical improvement, and neurophysiological, collected pre-intervention, post-intervention and post-placebo.

Studieoversikt

Studietype

Intervensjonell

Registrering (Antatt)

90

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Studiesteder

    • Ba
      • Bari, Ba, Italia, 70025
        • Rekruttering
        • Istituti Clinici Scientifici Maugeri
        • Ta kontakt med:
          • Simona Spaccavento

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år og eldre (Voksen, Eldre voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  • Age > 18 years
  • Post-stroke aphasia
  • Post-stroke neglect
  • Patients with disorders of consciusness (DOC)

Exclusion Criteria:

  • No auditory injury
  • no hystory of neurological disease
  • No hystory of psychiatric disease
  • Previous stroke
  • use of alcohol and drugs
  • premorbid dementia

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Behandling
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Dobbelt

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Group 1

Group 1 will receive tEs combined with music stimulation for 2 weeks, 1 week of wash out, then sham stimulation combined with noise (placebo) for other 2 weeks.

music

Eksperimentell: Group 2

Group 2 will receive sham stimulation and noise (placebo) for the first 2 weeks, then 1 week wash out, and finally tEs and music stimulation for other 2 weeks.

music

Eksperimentell: Group 3

Group 3 will receive only music stimulation and sham stimulation for 2 weeks, 1 week of wash out, then sham stimulation and noise (placebo) for another 2 weeks.

music

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Neuropsychological outcomes
Tidsramme: Change from baseline Coma Recovery Scale- Revised at 2 weeks and 4 weeks

-Coma Recovery Scale-Revised (CRS-R) - (0-23). High score means a better outcome.

Change from baseline Coma Recovery Scale- Revised at 2 weeks and 4 weeks
Neuropsychological outcomes
Tidsramme: Change from baseline Disability Rating Scale at 2 weeks and 4 weeks

Disability Rating Scale (DRS) - (0-29). High score means a worse outcome.

Change from baseline Disability Rating Scale at 2 weeks and 4 weeks
Neuropsychological outcomes
Tidsramme: Change from baseline Rancho Levels of Cognitive Functioning at 2 weeks and 4 weeks

Rancho Levels of Cognitive Functioning (LCF) - (1-8). High score means a better outcome.

Change from baseline Rancho Levels of Cognitive Functioning at 2 weeks and 4 weeks
Neuropsychological outcomes
Tidsramme: Change from baseline Glasgow Outcome Scale- Extended at 2 weeks and 4 weeks

Glasgow Outcome Scale- Extended (GOS-E) - (1-8). High score means a better outcome.

Change from baseline Glasgow Outcome Scale- Extended at 2 weeks and 4 weeks
Neuropsychological outcomes
Tidsramme: Change from baseline Aachener Aphasie Test at 2 weeks and 4 weeks

Aachener Aphasie Test (AAT). This test includes six subtests: spontaneous speech, token test, repetition, written language, naming, and comprehension.

Spontaneous speech is structured in six parts (0-30). High score means a better performance; Token test is composed by 50 items; for the score the number of error id considered (0-50).

Repetition sub test is composed by 50 items; for each item the score range from 0 to 3; high score means better outcome (0-150).

Written language subtest is composed by 30 items; for each item the score range from 0 to 3; high score means better outcome (0-90).

Naming subtest is composed by 40 items; for each item the score range from 0 to 3; high score means better outcome (0-120).

Comprehension subtest is composed by 40 items; for each item the score range from 0 to 3; high score means better outcome (0-120).

Change from baseline Aachener Aphasie Test at 2 weeks and 4 weeks
Neuropsychological outcomes
Tidsramme: Change from baseline Italian version of Functional Outcome Questionnaire for Aphasie at 2 weeks and 4 weeks

Italian version of Functional Outcome Questionnaire for Aphasie (FOQ-A) - (32-160). High score means a better outcome.

Change from baseline Italian version of Functional Outcome Questionnaire for Aphasie at 2 weeks and 4 weeks
Neuropsychological outcomes
Tidsramme: Change from baseline Functional Assessment Measure - Cognitive subscale at 2 weeks and 4 weeks

Functional Assessment Measure - Cognitive subscale - (FAM) - (14-98); high score means a better outcome.

Change from baseline Functional Assessment Measure - Cognitive subscale at 2 weeks and 4 weeks
Neuropsychological outcomes
Tidsramme: Change from baseline Quality of Life Questionnaire for aphasics at 2 weeks and 4 weeks

Quality of Life questionnaire for Aphasics (QLQA) - (0-148); High score means a better outcome.

Change from baseline Quality of Life Questionnaire for aphasics at 2 weeks and 4 weeks
Neuropsychological outcomes
Tidsramme: Change from baseline The semi-structured scale for functional evaluation of personal neglect at 2 weeks and 4 weeks

The semi-structured scale for functional evaluation of personal neglect - (0-9); High score means a worse outcome.

Change from baseline The semi-structured scale for functional evaluation of personal neglect at 2 weeks and 4 weeks
Neuropsychological outcomes
Tidsramme: Change from baseline Barrage Test at 2 weeks and 4 weeks

Barrage test (0-36). High score means a better outcome.

Change from baseline Barrage Test at 2 weeks and 4 weeks
Neuropsychological outcomes
Tidsramme: Change from baseline Letter cancellation test at 2 weeks and 4 weeks

Letter cancellation test - (0-104). High score means a better outcome.

Change from baseline Letter cancellation test at 2 weeks and 4 weeks
Neuropsychological outcomes
Tidsramme: Change from baseline Sentence reading test at 2 weeks and 4 weeks

Sentence reading test (0-6). High score means a worse outcome.

Change from baseline Sentence reading test at 2 weeks and 4 weeks
Neuropsychological outcomes
Tidsramme: Change from baseline Wundt-Jastrow area illusion test at 2 weeks and 4 weeks

Wundt-Jastrow area illusion test (0-20). High score means a worse outcome.

Change from baseline Wundt-Jastrow area illusion test at 2 weeks and 4 weeks
Neuropsychological outcomes
Tidsramme: Change from baseline The semi structured scale for the functional evaluation of extrapersonal neglect at 2 weeks and 4 weeks

The semi structured scale for the functional evaluation of extrapersonal neglect (0-9). High score means a worse outcome.

Change from baseline The semi structured scale for the functional evaluation of extrapersonal neglect at 2 weeks and 4 weeks
Neurophysiological outcome
Tidsramme: Change from baseline oscillation at 2 weeks and 4 weeks

The ratio of fast (8-30 Hz, α-β) to slow (2-8 Hz, δ-θ) oscillation amplitude at the midline electrodes (Fz, Cz, Pz, Oz) will be measured and compared pre- and post intervention."

Change from baseline oscillation at 2 weeks and 4 weeks

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Caregiver psychological distress
Tidsramme: Change from baseline Back depression Inventory II at 2 weeks and 4 weeks

Back depression Inventory II (BDI II) - (0-63). High score means a worse outcome.

Change from baseline Back depression Inventory II at 2 weeks and 4 weeks
Caregiver psychological distress
Tidsramme: Change from baseline State-trait anxiety inventory; at 2 weeks and 4 weeks

State-trait anxiety inventory (STAI-Y). It is composed by two scales: STAI-Y State (20-80) and STAI-Y Trait (20-80). High score means a worse outcome.

Change from baseline State-trait anxiety inventory; at 2 weeks and 4 weeks
Caregiver psychological distress
Tidsramme: Change from baseline Questionario psicofisiologico (CBA) at 2 weeks and 4 weeks

Psychophysiological Questionnaire (30-120). WHOQOL-BREF.

Change from baseline Questionario psicofisiologico (CBA) at 2 weeks and 4 weeks
Caregiver psychological distress
Tidsramme: Change from baseline Prolonged grief disorder -12 at 2 weeks and 4 weeks

Prolonged grief disorder -12 (PG-12) - (11-55). High score means a worse outcome.

Change from baseline Prolonged grief disorder -12 at 2 weeks and 4 weeks
Caregiver psychological distress
Tidsramme: Change from baseline Family strain questionnaire at 2 weeks and 4 weeks

Family strain questionnaire (FSQ) - (1-44). High score means a worse outcome.

Change from baseline Family strain questionnaire at 2 weeks and 4 weeks
Caregiver psychological distress
Tidsramme: Change from baseline Wolrd health organization - quality of life at 2 weeks and 4 weeks

better outcome.

Change from baseline Wolrd health organization - quality of life at 2 weeks and 4 weeks

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Publikasjoner og nyttige lenker

Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

1. september 2022

Primær fullføring (Antatt)

31. desember 2026

Studiet fullført (Antatt)

31. desember 2026

Datoer for studieregistrering

Først innsendt

16. november 2022

Først innsendt som oppfylte QC-kriteriene

30. januar 2023

Først lagt ut (Faktiske)

31. januar 2023

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

10. november 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

5. november 2026

Sist bekreftet

1. november 2026

Mer informasjon

Begreper knyttet til denne studien

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere